Skip to main content

Advertisement

Figure 5 | BMC Gastroenterology

Figure 5

From: Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients

Figure 5

Cumulative survival rates between corresponding groups. (A) There was no significant difference between the IFN-treated hepatitis C group (Group A) and the general resident group (Group A). (B) There was a significant difference between the hepatitis C group not receiving IFN treatment (Group B) and the general resident group (Group B) (p < 0.0001). (C) There was no significant difference between the hepatitis C group that achieved SVR by IFN treatment (Group A1) and the general resident group (Group A1). (D) There was no significant difference between the IFN treatment group with non-SVR in the hepatitis C group (Group A2) and the general resident group (Group A2) (p = 0.153). All survival rates were calculated using the Kaplan–Meier method. Solid and dotted lines represent the hepatitis C and general resident groups, respectively.

Back to article page